Skip to main content
. Author manuscript; available in PMC: 2023 Oct 6.
Published in final edited form as: Chest. 2019 Jul 24;157(1):89–98. doi: 10.1016/j.chest.2019.06.033

Table 3. Univariate assessment of invasive and non-invasive variables.

Hazard ratio (95% CI) Univariate p-value
Age 1.01 (0.98-1.03) 0.6
Composite physiological index 1.06 (1.03-1.09) <0.001
Male gender 1.51 (0.95-2.38) 0.08
Diagnosis of Idiopathic pulmonary fibrosis 1.94 (1.21-3.10) 0.006
Fibrosis score (Increase by 10%) 1.37 (1.15-1.63) <0.001
Vasodilator treatment 0.62 (0.40-0.97) 0.04
Right heart catheter haemodynamics
Mean pulmonary artery pressure 1.00 (0.98-1.03) 0.7
Mean pulmonary artery pressure ≥25mmHg 1.15 (0.68-1.97) 0.6
Pulmonary vascular resistance 1.03 (0.96-1.10) 0.4
Cardiac Output 0.88 (0.73-1.01) 0.2
Echocardiography
Right ventricular systolic pressure 1.01 (0.99-1.01) 0.3
Right atrial area 1.00 (0.97-1.04) 0.8
Pulmonary acceleration time 1.00 (0.99-1.02) 0.7
RV:LVecho 1.07 (0.71-1.60) 0.7
Transannular plane systolic excursion 0.97 (0.93-1.02) 0.3
RV Fractional area change 1.01 (0.98-1.04) 0.5
CT Pulmonary Angiography
MPA diameter (per 1mm increase) 1.01 (0.96-1.06) 0.7
MPA diameter (>32mm) 1.50 (0.93-2.43) 0.1
MPADiameter:Aorta ratio 0.97 (0.84-1.13) 0.7
RV subjectively larger than LV 2.08 (1.16-3.74) 0.01
RV:LVaxial ratio 1.04 (0.99-1.07) 0.1
RV:LVaxial ratio ≥ 1.0 2.17 (1.19-3.97) 0.01
RV:LVlargest ratio 1.06 (1.01-1.11) 0.02
RV:LVlargest ratio ≥ 1.0 3.26 (1.49-7.15) 0.003
Ventricular septal bowing 1.30 (0.81-1.96) 0.3
RAtransverse 1.01 (0.99-1.03) 0.3
RAlongitudinal 1.02 (0.99-1.05) 0.09

Abbreviations: As per table 2.